Dr. Horbinski hails from Buffalo, NY, where he completed his combined M.D., Ph.D. training at the State University of New York at Buffalo. He then did an Anatomic Pathology residency and a Neuropathology fellowship at the University of Pittsburgh. As a full tenured professor at Northwestern University, Dr. Horbinski directs the Neuropathology Division, the Nervous System Tumor Bank, and the Lurie Comprehensive Cancer Center Pathology Core Facility. Dr. Horbinski’s clinical specialty is molecular diagnostics of brain tumors. His major areas of research involve the effect of IDH mutations on the glioma microenvironment, predicting venous thromboembolism in glioma patients, and repurposing chemotherapies against aggressive meningiomas. He has also helped pioneer the use of genomic DNA methylation profiling in the diagnosis and prognostic stratification of primary and metastatic brain tumors. To date, Dr. Horbinski has authored over 210 peer-reviewed publications, including original work from his laboratory in journals such as the Journal of Clinical Investigation, Blood, and Neuro Oncology. He has obtained extramural research support as a principal investigator from multiple sources, including the NIH and the American Brain Tumor Association. His NCI-funded brain tumor bank has supported over 100 intramural and extramural research projects, including seminal clinical trials involving nanotherapy and oncolytic virotherapy in glioblastomas. He has delivered over 110 invited talks and platform presentations on brain tumors at a variety of national and international settings. Dr. Horbinski is an Associate Editor of Neuro Oncology and Neuro Oncology Advances, and is on the editorial board of the top two neuropathology journals, Acta Neuropathologica and Brain Pathology.